Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota
ConclusionCurcumin sensitizes response to Ara-C through regulating microbiota, highlighting the importance of intestinal intact strengthening in chemoresistant therapy. Moreover, aiming at cholesterol synthesis is promising in AML treatment.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Chemotherapy | Cholesterol | Drugs & Pharmacology | Leukemia | Study | Turmeric